Amsalih, Amaarah .

HRN: 21-83-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
CEFUROXIME 1.5GM (VIAL)
03/27/2023
04/02/2023
IVT
260mg
Q8
URTI
Waiting Final Action 
03/27/2023
MUPIROCIN 2%, 15G (TUBE)
03/27/2023
04/02/2023
TOPICAL
Pea Size
BID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: